Morning-after pill under review
4th February 2014
By Emily Dunn
The review will assess whether changes should be made to the product information for emergency contraceptives containing levonorgestrel or ulipristal, which is not registered in Australia.
This includes over-the-counter drugs NorLevo, Levonelle/Postinor and European brand Levodonna as well as the prescription-only EllaOne, which contains ulipristal.
In November, the EMA ordered HRA Pharma, the French manufacturer of NorLevo (levonorgestrel 750mcg), to change the PI to include weight limits,